ArticleBMC cancer2024

Integrating trans-omics, cellular experiments and clinical validation to identify ILF2 as a diagnostic serum biomarker and therapeutic target in gastric cancer.

Shao-Song Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.